Theravance Biopharma Inc. (TBPH) NASDAQ

$8.96 (0.05) (-0.56%)

Market Cap: $433.96M

As of 03/28/24 03:59 PM EDT. Market closed.

(TBPH)

Theravance Biopharma Inc. (TBPH)
NASDAQ

$8.96
(0.05) (-0.56%)

Market Cap: $433.96M

As of 03/28/24 03:59 PM EDT. Market closed.

Add to Portfolio

theravance biopharma is a biopharmaceutical company with one approved product, vibativ® (telavancin), that was discovered and developed internally, a pipeline of internally discovered product candidates and strategic collaborations with pharmaceutical ... read more

theravance biopharma is a biopharmaceutical company with one approved product, vibativ® (telavancin), that was discovered and developed internally, a pipeline of internally discovered product candidates and strategic collaborations with pharmaceutical companies. read less

COMPANY PROFILE
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO
Rick Winningham
Full Time Employees
270
CEO Compensation (Base)
$956,600
CEO Compensation (Total)
$2.52M
URL
Address
Ugland House, South Church Street, Grand Cayman, George Town, KY1-1104.
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO
Rick Winningham
Full Time Employees
270
CEO Compensation (Base)
$956,600
CEO Compensation (Total)
$2.52M
URL
Address
Ugland House, South Church Street, Grand Cayman, George Town, KY1-1104.
PRICE CHART FOR THERAVANCE BIOPHARMA INC
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$8.85
Previous Close
$9.01
Days Range
$8.80 - $9.02
52 week range
$8.21 - $12.03
Volume
401,710
Avg. Volume (30 days)
353,365
Market Cap
$433.96M
Dividend Yield
-
P/E
(7.86)
Shares Outstanding
48,164,708
Open
$8.85
Previous Close
$9.01
Days Range
$8.80 - $9.02
52 week range
$8.21 - $12.03
Volume
401,710
Avg. Volume (30 days)
353,365
Market Cap
$433.96M
Dividend Yield
-
P/E
(7.86)
Shares Outstanding
48,164,708
FINANCIAL STATEMENTS FOR THERAVANCE BIOPHARMA INC
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR THERAVANCE BIOPHARMA INC
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
Winningham Rick ECHIEF EXECUTIVE OFFICERMar 15, 2024 Option Exercise$8.642,70423,3631,561,473Mar 19, 2024, 06:06 PM
Winningham Rick ECHIEF EXECUTIVE OFFICERFeb 20, 2024 Option Exercise$8.9237,196331,7881,558,769Feb 22, 2024, 08:14 PM
Sawaf AzizSVP & CHIEF FINANCIAL OFFICERFeb 20, 2024 Option Exercise$8.9217,036151,961238,636Feb 22, 2024, 08:11 PM
Miller AineSVP, DEV & HEAD OF IRE OFFICEFeb 20, 2024 Option Exercise$8.9211,782105,095133,534Feb 22, 2024, 08:10 PM
Grimaud Brett A.SVP, GEN COUNSEL AND SECRETARYFeb 20, 2024 Option Exercise$8.9217,595156,947260,684Feb 22, 2024, 08:08 PM
GRAHAM RICHARD ASVP, RESEARCH & DEVELOPMENTFeb 20, 2024 Option Exercise$8.9219,294172,102314,915Feb 22, 2024, 08:06 PM
Farnum RhondaSVP, COMM & MEDICAL AFFAIRSFeb 20, 2024 Option Exercise$8.9218,219162,513312,987Feb 22, 2024, 08:04 PM
Farnum RhondaSVP, COMM & MEDICAL AFFAIRSFeb 22, 2024 Sale$8.711,25410,922311,733Feb 22, 2024, 08:04 PM
Winningham Rick ECHIEF EXECUTIVE OFFICERNov 20, 2023 Option Exercise$10.3715,804163,8871,595,965Nov 22, 2023, 06:16 PM
Sawaf AzizSVP & CHIEF FINANCIAL OFFICERNov 20, 2023 Option Exercise$10.376,18764,159255,672Nov 22, 2023, 06:14 PM
Grimaud Brett A.SVP, GEN COUNSEL AND SECRETARYNov 20, 2023 Option Exercise$10.377,36376,354278,279Nov 22, 2023, 06:11 PM
GRAHAM RICHARD ASVP, RESEARCH & DEVELOPMENTNov 20, 2023 Option Exercise$10.3712,630130,973334,209Nov 22, 2023, 06:10 PM
Farnum RhondaSVP, COMM & MEDICAL AFFAIRSNov 20, 2023 Option Exercise$10.377,98282,773332,584Nov 22, 2023, 06:07 PM
Farnum RhondaSVP, COMM & MEDICAL AFFAIRSNov 21, 2023 Sale$10.291,37814,180331,206Nov 22, 2023, 06:07 PM
GRAHAM RICHARD ASVP, RESEARCH & DEVELOPMENTNov 14, 2023 Sale$10.222,48225,366346,839Nov 16, 2023, 06:16 PM
GRAHAM RICHARD ASVP, RESEARCH & DEVELOPMENTOct 16, 2023 Sale$9.032,48222,412334,321Oct 18, 2023, 06:54 PM
GRAHAM RICHARD ASVP, RESEARCH & DEVELOPMENTSep 14, 2023 Sale$9.892,48224,547336,803Sep 18, 2023, 06:08 PM
Farnum RhondaSVP, COMM & MEDICAL AFFAIRSAug 22, 2023 Sale$9.471,80717,112340,566Aug 24, 2023, 06:05 PM
Winningham Rick ECHIEF EXECUTIVE OFFICERAug 20, 2023 Option Exercise$9.7015,804153,2991,611,769Aug 22, 2023, 06:19 PM
Sawaf AzizSVP & CHIEF FINANCIAL OFFICERAug 20, 2023 Option Exercise$9.707,11469,006261,859Aug 22, 2023, 06:17 PM
Grimaud Brett A.SVP, GEN COUNSEL AND SECRETARYAug 20, 2023 Option Exercise$9.708,91286,446285,297Aug 22, 2023, 06:15 PM
GRAHAM RICHARD ASVP, RESEARCH & DEVELOPMENTAug 20, 2023 Option Exercise$9.7010,461101,472339,285Aug 22, 2023, 06:13 PM
Farnum RhondaSVP, COMM & MEDICAL AFFAIRSAug 20, 2023 Option Exercise$9.7010,460101,462342,373Aug 22, 2023, 06:10 PM
GRAHAM RICHARD ASVP, RESEARCH & DEVELOPMENTAug 11, 2023 Sale$9.992,32223,197349,746Aug 15, 2023, 06:09 PM
GRAHAM RICHARD ASVP, RESEARCH & DEVELOPMENTJul 14, 2023 Sale$9.842,32222,848352,068Jul 18, 2023, 06:14 PM
GRAHAM RICHARD ASVP, RESEARCH & DEVELOPMENTJun 14, 2023 Sale$10.692,32224,822354,390Jun 16, 2023, 06:14 PM
Farnum RhondaSVP, COMM & MEDICAL AFFAIRSJun 08, 2023 Sale$11.131,79019,923352,833Jun 12, 2023, 06:08 PM
Winningham Rick ECHIEF EXECUTIVE OFFICERMay 20, 2023 Option Exercise$11.2115,804177,1631,627,573May 23, 2023, 07:48 PM
Sawaf AzizSVP & CHIEF FINANCIAL OFFICERMay 20, 2023 Option Exercise$11.218,74498,020268,973May 23, 2023, 07:46 PM
Grimaud Brett A.SVP, GEN COUNSEL AND SECRETARYMay 20, 2023 Option Exercise$11.2111,469128,567294,209May 23, 2023, 07:44 PM
GRAHAM RICHARD ASVP, RESEARCH & DEVELOPMENTMay 20, 2023 Option Exercise$11.2110,460117,257356,712May 23, 2023, 07:41 PM
Farnum RhondaSVP, COMM & MEDICAL AFFAIRSMay 20, 2023 Option Exercise$11.215,56762,406354,623May 23, 2023, 07:40 PM
GRAHAM RICHARD ASVP, RESEARCH & DEVELOPMENTMay 15, 2023 Sale$11.262,32226,146367,172May 17, 2023, 06:17 PM
GRAHAM RICHARD ASVP, RESEARCH & DEVELOPMENTApr 14, 2023 Sale$11.882,32327,597369,494Apr 18, 2023, 05:49 PM
GRAHAM RICHARD ASVP, RESEARCH & DEVELOPMENTMar 14, 2023 Sale$10.322,32323,973371,817Mar 16, 2023, 07:04 PM
Farnum RhondaSVP, COMM & MEDICAL AFFAIRSMar 09, 2023 Sale$10.204,00040,800360,190Mar 13, 2023, 05:57 PM
GRAHAM RICHARD ASVP, RESEARCH & DEVELOPMENTMar 06, 2023 Sale$10.052,32323,346374,140Mar 08, 2023, 07:34 PM
Winningham Rick ECHIEF EXECUTIVE OFFICERFeb 20, 2023 Option Exercise$10.4437,420390,6651,313,377Feb 22, 2023, 07:29 PM
Sawaf AzizSVP & CHIEF FINANCIAL OFFICERFeb 20, 2023 Option Exercise$10.446,78370,815197,717Feb 22, 2023, 07:27 PM
Grimaud Brett A.SVP, GEN COUNSEL AND SECRETARYFeb 20, 2023 Option Exercise$10.4410,198106,467229,958Feb 22, 2023, 07:23 PM
GRAHAM RICHARD ASVP, RESEARCH & DEVELOPMENTFeb 20, 2023 Option Exercise$10.4412,057125,875301,463Feb 22, 2023, 07:21 PM
Farnum RhondaSVP, COMM & MEDICAL AFFAIRSFeb 20, 2023 Option Exercise$10.447,11974,322289,190Feb 22, 2023, 07:18 PM
Winningham Rick ECHIEF EXECUTIVE OFFICERDec 14, 2022 Sale$11.1950,000559,5001,350,797Dec 16, 2022, 07:36 PM
GRAHAM RICHARD ASVP, RESEARCH & DEVELOPMENTDec 01, 2022 Sale$10.732,08422,361313,520Dec 05, 2022, 05:59 PM
O'Connor DonalDirectorNov 22, 2022 Option Exercise$10.5010,000105,00043,886Nov 23, 2022, 06:57 PM
Winningham Rick ECHIEF EXECUTIVE OFFICERNov 20, 2022 Option Exercise$10.8515,804171,4731,409,797Nov 22, 2022, 04:09 PM
Hindman Andrew A.SVP, CHIEF FINANCIAL OFFICERNov 20, 2022 Option Exercise$10.8525,057271,868384,714Nov 22, 2022, 04:07 PM
Hindman Andrew A.SVP, CHIEF FINANCIAL OFFICERNov 18, 2022 Sale$11.0265,000716,242409,771Nov 22, 2022, 04:07 PM
GRAHAM RICHARD ASVP, RESEARCH & DEVELOPMENTNov 20, 2022 Option Exercise$10.8527,350296,748315,604Nov 22, 2022, 04:04 PM
Farnum RhondaSVP, COMM & MEDICAL AFFAIRSNov 20, 2022 Option Exercise$10.8523,268252,458296,309Nov 22, 2022, 04:02 PM
GRAHAM RICHARD ASVP, RESEARCH & DEVELOPMENTNov 16, 2022 Option Exercise$11.202,80031,360342,954Nov 17, 2022, 07:53 PM
GSK PLCFormer 10% OwnerSep 16, 2022 Option Exercise$9.759,644,80794,036,8680Sep 20, 2022, 04:16 PM
Winningham Rick ECHIEF EXECUTIVE OFFICERAug 19, 2022 Option Exercise$9.3415,804147,6091,424,784Aug 23, 2022, 07:03 PM
Hindman Andrew A.SVP, CHIEF FINANCIAL OFFICERAug 19, 2022 Option Exercise$9.3425,676239,814473,507Aug 23, 2022, 07:00 PM
GRAHAM RICHARD ASVP, DEVELOPMENTAug 19, 2022 Option Exercise$9.3418,991177,376345,754Aug 23, 2022, 06:57 PM
Farnum RhondaSVP, COMM & MEDICAL AFFAIRSAug 19, 2022 Option Exercise$9.3410,41397,257319,577Aug 23, 2022, 06:54 PM
GRAHAM RICHARD ASVP, DEVELOPMENTAug 16, 2022 Sale$9.714,90647,640364,745Aug 18, 2022, 06:05 PM
GRAHAM RICHARD ASVP, DEVELOPMENTAug 09, 2022 Sale$8.7915,086132,606369,651Aug 11, 2022, 06:55 PM
Winningham Rick ECHIEF EXECUTIVE OFFICERMay 20, 2022 Option Exercise$8.7411,02596,3581,440,588May 24, 2022, 07:19 PM
Hindman Andrew A.SVP, CHIEF FINANCIAL OFFICERMay 20, 2022 Option Exercise$8.743,36529,410479,183May 24, 2022, 07:17 PM
GRAHAM RICHARD ASVP, DEVELOPMENTMay 20, 2022 Option Exercise$8.743,94734,497384,737May 24, 2022, 07:14 PM
Farnum RhondaSVP, COMM & MEDICAL AFFAIRSMay 20, 2022 Option Exercise$8.742,20019,228331,071May 24, 2022, 07:11 PM
Farnum RhondaSVP, COMM & MEDICAL AFFAIRSMay 23, 2022 Sale$8.931,0819,653329,990May 24, 2022, 07:11 PM
Farnum RhondaSVP, COMM & MEDICAL AFFAIRSFeb 28, 2022 Sale$10.162,35623,947333,271Mar 02, 2022, 07:08 PM
Winningham Rick ECHIEF EXECUTIVE OFFICERFeb 18, 2022 Option Exercise$9.6122,710218,2431,279,300Feb 23, 2022, 06:38 PM
PITZER KENNETH RSVP, PROD STRAT & COMM PLNGFeb 18, 2022 Option Exercise$9.6127,299262,343380,123Feb 23, 2022, 06:34 PM
Hindman Andrew A.SVP, CHIEF FINANCIAL OFFICERFeb 18, 2022 Option Exercise$9.6125,973249,601481,285Feb 23, 2022, 06:29 PM
GRAHAM RICHARD ASVP, DEVELOPMENTFeb 18, 2022 Option Exercise$9.6120,377195,823388,684Feb 23, 2022, 06:25 PM
Farnum RhondaSVP, COMM & MEDICAL AFFAIRSFeb 18, 2022 Option Exercise$9.6111,824113,629335,627Feb 23, 2022, 06:22 PM
BRADY ANNPRESIDENT, TBILFeb 18, 2022 Option Exercise$9.618,36980,426110,319Feb 23, 2022, 06:18 PM
BRADY ANNPRESIDENT, TBILNov 19, 2021 Option Exercise$8.363,16926,493118,688Nov 23, 2021, 08:26 PM
PASQUALONE FRANKSVP, CHIEF BUSINESS OFFICERNov 19, 2021 Option Exercise$8.363,77931,592429,783Nov 23, 2021, 08:25 PM
PITZER KENNETH RSVP, PROD STRAT & COMM PLNGNov 19, 2021 Option Exercise$8.364,31036,032355,422Nov 23, 2021, 08:24 PM
GRAHAM RICHARD ASVP, DEVELOPMENTNov 19, 2021 Option Exercise$8.364,26335,639169,061Nov 23, 2021, 08:23 PM
Hindman Andrew A.SVP, CHIEF FINANCIAL OFFICERNov 19, 2021 Option Exercise$8.361,35011,286167,258Nov 23, 2021, 08:22 PM
WORBOYS PHILIP DSVP, RESEARCH & TRANSL SCIENCENov 19, 2021 Option Exercise$8.364,31036,032330,752Nov 23, 2021, 08:21 PM
SABESAN VIJAYSVP, TECHNICAL OPERATIONSNov 19, 2021 Option Exercise$8.365,19143,397235,524Nov 23, 2021, 08:21 PM
Winningham Rick ECHIEF EXECUTIVE OFFICERNov 19, 2021 Option Exercise$8.3611,40495,3371,302,010Nov 23, 2021, 08:20 PM
WORBOYS PHILIP DSVP, Research & Transl ScienceAug 20, 2021 Option Exercise$14.054,30760,513335,062Aug 24, 2021, 07:07 PM
Winningham Rick EChief Executive OfficerAug 20, 2021 Option Exercise$14.0511,404160,2261,313,414Aug 24, 2021, 07:05 PM
Shafer Bradford JEVP, Gen. Counsel, SecretaryAug 20, 2021 Option Exercise$14.054,30760,513277,831Aug 24, 2021, 07:03 PM
SABESAN VIJAYSVP, Technical OperationsAug 20, 2021 Option Exercise$14.055,19372,962240,715Aug 24, 2021, 07:01 PM
PITZER KENNETH RSVP, Prod Strat & Comm PlngAug 20, 2021 Option Exercise$14.054,30760,513359,732Aug 24, 2021, 06:59 PM
PASQUALONE FRANKSVP, Chief Business OfficerAug 20, 2021 Option Exercise$14.053,77953,095433,562Aug 24, 2021, 06:57 PM
Hindman Andrew A.SVP, Chief Financial OfficerAug 20, 2021 Option Exercise$14.0517,464245,369167,380Aug 24, 2021, 06:55 PM
GRAHAM RICHARD ASVP, DevelopmentAug 20, 2021 Option Exercise$14.056,81995,807173,205Aug 24, 2021, 06:52 PM
BRADY ANNPresident, TBILAug 20, 2021 Option Exercise$14.053,16944,524121,857Aug 24, 2021, 06:50 PM
Winningham Rick EChief Executive OfficerMay 20, 2021 Option Exercise$17.8011,404202,9911,324,818May 24, 2021, 06:19 PM
Shafer Bradford JEVP, Gen. Counsel, SecretaryMay 20, 2021 Option Exercise$17.804,31076,718282,138May 24, 2021, 06:18 PM
GRAHAM RICHARD ASVP, DevelopmentMay 20, 2021 Option Exercise$17.803,41060,698180,024May 24, 2021, 06:09 PM
BRADY ANNPresident, TBILMay 20, 2021 Option Exercise$17.803,16956,408125,026May 24, 2021, 06:07 PM
WORBOYS PHILIP DSVP, Research & Transl ScienceMar 09, 2021 Sale$20.008,829176,580343,679Mar 11, 2021, 07:00 PM
WORBOYS PHILIP DSVP, Research & Transl ScienceFeb 20, 2021 Option Exercise$18.7931,887599,157352,508Feb 23, 2021, 06:20 PM
Winningham Rick EChief Executive OfficerFeb 20, 2021 Option Exercise$18.79110,3482,073,4391,334,821Feb 23, 2021, 06:17 PM
Shafer Bradford JEVP, Gen. Counsel, SecretaryFeb 20, 2021 Option Exercise$18.7931,869598,819285,047Feb 23, 2021, 06:15 PM
SABESAN VIJAYSVP, Technical OperationsFeb 20, 2021 Option Exercise$18.798,343156,765249,701Feb 23, 2021, 06:13 PM
PITZER KENNETH RSVP, Prod Strat & Comm PlngFeb 20, 2021 Option Exercise$18.7931,931599,984368,349Feb 23, 2021, 06:10 PM
PASQUALONE FRANKSVP, Chief Business OfficerFeb 20, 2021 Option Exercise$18.7926,961506,597439,719Feb 23, 2021, 06:09 PM
Hindman Andrew A.SVP, Chief Financial OfficerFeb 20, 2021 Option Exercise$18.793,98474,859184,704Feb 23, 2021, 06:07 PM
HAUMANN BRETT KChief Medical OfficerFeb 20, 2021 Option Exercise$18.7935,672670,277242,499Feb 23, 2021, 06:05 PM
GRAHAM RICHARD ASVP, DevelopmentFeb 20, 2021 Option Exercise$18.796,597123,958182,152Feb 23, 2021, 06:03 PM
BRADY ANNPresident, TBILFeb 20, 2021 Option Exercise$18.7910,092189,629128,195Feb 23, 2021, 06:01 PM
GRAHAM RICHARD ASVP, DevelopmentDec 14, 2020 Sale$19.477,500146,058123,749Dec 16, 2020, 06:09 PM
WORBOYS PHILIP DSVP, Research & Transl ScienceDec 03, 2020 Sale$18.004,24676,428319,395Dec 07, 2020, 06:42 PM
WORBOYS PHILIP DSVP, Research & Transl ScienceNov 20, 2020 Option Exercise$17.214,80782,728323,641Nov 24, 2020, 06:25 PM
Winningham Rick EChief Executive OfficerNov 20, 2020 Option Exercise$17.2113,946240,0111,275,169Nov 24, 2020, 06:24 PM
Shafer Bradford JEVP, Gen. Counsel, SecretaryNov 20, 2020 Option Exercise$17.214,80782,728251,916Nov 24, 2020, 06:22 PM
SABESAN VIJAYSVP, Technical OperationsNov 20, 2020 Option Exercise$17.213,79865,364193,044Nov 24, 2020, 06:21 PM
PITZER KENNETH RSVP, Prod Strat & Comm PlngNov 20, 2020 Option Exercise$17.214,80782,728335,280Nov 24, 2020, 06:19 PM
PASQUALONE FRANKSVP, Chief Comm Ops OfficerNov 20, 2020 Option Exercise$17.214,21472,523401,680Nov 24, 2020, 06:17 PM
HAUMANN BRETT KChief Medical OfficerNov 20, 2020 Option Exercise$17.214,63979,837278,171Nov 24, 2020, 06:16 PM
GRAHAM RICHARD ASVP, DevelopmentNov 20, 2020 Option Exercise$17.213,87666,706131,249Nov 24, 2020, 06:14 PM
BRADY ANNPresident, TBILNov 20, 2020 Option Exercise$17.212,29239,44598,287Nov 24, 2020, 06:13 PM
WORBOYS PHILIP DSVP, Research & Transl ScienceAug 20, 2020 Option Exercise$18.224,80487,529328,448Aug 24, 2020, 06:38 PM
WORBOYS PHILIP DSVP, Research & Transl ScienceAug 20, 2020 Sale$18.0017,103307,854333,252Aug 24, 2020, 06:38 PM
Winningham Rick EChief Executive OfficerAug 20, 2020 Option Exercise$18.2213,946254,0961,289,115Aug 24, 2020, 06:36 PM
Shafer Bradford JEVP, Gen. Counsel, SecretaryAug 20, 2020 Option Exercise$18.224,80487,529256,723Aug 24, 2020, 06:34 PM
SABESAN VIJAYSVP, Technical OperationsAug 20, 2020 Option Exercise$18.223,79969,218196,842Aug 24, 2020, 06:32 PM
PITZER KENNETH RSVP, Prod Strat & Comm PlngAug 20, 2020 Option Exercise$18.224,80487,529340,087Aug 24, 2020, 06:29 PM
PASQUALONE FRANKSVP, Chief Comm Ops OfficerAug 20, 2020 Option Exercise$18.224,21476,779405,894Aug 24, 2020, 06:27 PM
Hindman Andrew A.SVP, Chief Financial OfficerAug 20, 2020 Option Exercise$18.224,32378,765123,135Aug 24, 2020, 06:24 PM
HAUMANN BRETT KChief Medical OfficerAug 20, 2020 Option Exercise$18.224,64684,650307,810Aug 24, 2020, 06:21 PM
HAUMANN BRETT KChief Medical OfficerAug 21, 2020 Sale$18.2925,000457,240282,810Aug 24, 2020, 06:21 PM
GRAHAM RICHARD ASVP, DevelopmentAug 20, 2020 Option Exercise$18.226,598120,216107,625Aug 24, 2020, 06:20 PM
BRADY ANNPresident, TBILAug 20, 2020 Option Exercise$18.222,29241,760100,579Aug 24, 2020, 06:19 PM
WORBOYS PHILIP DSVP, Research & Transl ScienceMay 20, 2020 Option Exercise$26.674,807128,203350,355May 22, 2020, 06:14 PM
Winningham Rick EChief Executive OfficerMay 20, 2020 Option Exercise$26.6713,946371,9401,303,061May 22, 2020, 06:13 PM
Shafer Bradford JEVP, Gen. Counsel, SecretaryMay 20, 2020 Option Exercise$26.674,807128,203261,527May 22, 2020, 06:11 PM
SABESAN VIJAYSVP, Technical OperationsMay 20, 2020 Option Exercise$26.673,801101,373200,641May 22, 2020, 06:10 PM
PITZER KENNETH RSVP, Prod Strat & Comm PlngMay 20, 2020 Option Exercise$26.674,807128,203344,891May 22, 2020, 06:09 PM
PASQUALONE FRANKSVP, Chief Comm Ops OfficerMay 20, 2020 Option Exercise$26.674,214112,387410,108May 22, 2020, 06:07 PM
HAUMANN BRETT KSVP Clin Dev & Chief Med OfcMay 20, 2020 Option Exercise$26.674,212112,334312,456May 22, 2020, 06:06 PM
BRADY ANNPresident, TBILMay 20, 2020 Option Exercise$26.672,29261,128102,871May 22, 2020, 06:05 PM
WORBOYS PHILIP DSVP, Research & Transl ScienceFeb 20, 2020 Option Exercise$25.9029,105753,819354,750Feb 24, 2020, 07:16 PM
Winningham Rick EChief Executive OfficerFeb 20, 2020 Option Exercise$25.9096,8502,508,4151,315,605Feb 24, 2020, 07:15 PM
Shafer Bradford JEVP, Gen. Counsel, SecretaryFeb 20, 2020 Option Exercise$25.9029,402761,512264,932Feb 24, 2020, 07:13 PM
SABESAN VIJAYSVP, Technical OperationsFeb 20, 2020 Option Exercise$25.907,213186,817203,040Feb 24, 2020, 07:12 PM
PITZER KENNETH RSVP, Prod Strat & Comm PlngFeb 20, 2020 Option Exercise$25.9029,136754,622349,698Feb 24, 2020, 07:11 PM
PASQUALONE FRANKSVP, Chief Comm Ops OfficerFeb 20, 2020 Option Exercise$25.9024,392631,753412,920Feb 24, 2020, 07:10 PM
Hindman Andrew A.SVP, Chief Financial OfficerFeb 20, 2020 Option Exercise$25.907,060182,854106,490Feb 24, 2020, 07:08 PM
HAUMANN BRETT KSVP Clin Dev & Chief Med OfcFeb 20, 2020 Option Exercise$25.9033,608870,447316,668Feb 24, 2020, 07:07 PM
BRADY ANNPresident, TBILFeb 20, 2020 Option Exercise$25.905,948154,053105,163Feb 24, 2020, 07:05 PM
SABESAN VIJAYSVP, Technical OperationsDec 12, 2019 Sale$21.031,02721,598145,253Dec 16, 2019, 06:09 PM
WORBOYS PHILIP DSVP, Research & Transl ScienceNov 20, 2019 Option Exercise$17.602,27239,987264,855Nov 22, 2019, 06:28 PM
Winningham Rick EChief Executive OfficerNov 20, 2019 Option Exercise$17.608,678152,7331,074,455Nov 22, 2019, 06:26 PM
Shafer Bradford JEVP, Gen. Counsel, SecretaryNov 20, 2019 Option Exercise$17.603,56762,779175,334Nov 22, 2019, 06:25 PM
SABESAN VIJAYSVP, Technical OperationsNov 20, 2019 Option Exercise$17.601,47325,925146,280Nov 22, 2019, 06:24 PM
PITZER KENNETH RSVP, Prod Strat & Comm PlngNov 20, 2019 Option Exercise$17.602,27239,987259,834Nov 22, 2019, 06:23 PM
PASQUALONE FRANKSVP, Chief Comm Ops OfficerNov 20, 2019 Option Exercise$17.602,44743,067318,312Nov 22, 2019, 06:22 PM
HAUMANN BRETT KSVP Clin Dev & Chief Med OfcNov 20, 2019 Option Exercise$17.602,69247,379231,276Nov 22, 2019, 06:20 PM
BRADY ANNPresident, TBILNov 20, 2019 Option Exercise$17.601,07318,88571,111Nov 22, 2019, 06:18 PM
WORBOYS PHILIP DSVP, Translational ScienceAug 20, 2019 Option Exercise$21.512,27248,871267,127Aug 22, 2019, 06:08 PM
Winningham Rick EChief Executive OfficerAug 20, 2019 Option Exercise$21.518,678186,6641,083,133Aug 22, 2019, 06:07 PM
Shafer Bradford JEVP, Gen. Counsel, SecretaryAug 20, 2019 Option Exercise$21.513,08466,337178,901Aug 22, 2019, 06:06 PM
SABESAN VIJAYSVP, Technical OperationsAug 20, 2019 Option Exercise$21.511,47231,663147,753Aug 22, 2019, 06:05 PM
PITZER KENNETH RSVP, Prod Strat & Comm PlngAug 20, 2019 Option Exercise$21.512,27248,871262,106Aug 22, 2019, 06:03 PM
PASQUALONE FRANKSVP, Chief Comm Ops OfficerAug 20, 2019 Option Exercise$21.512,33550,226320,759Aug 22, 2019, 06:02 PM
HEGDE SHARATHCHANDRA SSVP, ResearchAug 20, 2019 Option Exercise$21.512,27248,871259,900Aug 22, 2019, 06:01 PM
HAUMANN BRETT KSVP Clin Dev & Chief Med OfcAug 20, 2019 Option Exercise$21.512,71058,292233,968Aug 22, 2019, 06:00 PM
BRADY ANNPresident, TBILAug 20, 2019 Option Exercise$21.511,07323,08072,184Aug 22, 2019, 05:58 PM
WORBOYS PHILIP DSVP, Translational ScienceMay 20, 2019 Option Exercise$19.842,27245,076269,399May 22, 2019, 06:19 PM
Winningham Rick EChief Executive OfficerMay 20, 2019 Option Exercise$19.848,678172,1721,091,811May 22, 2019, 06:17 PM
Shafer Bradford JEVP, Gen. Counsel, SecretaryMay 20, 2019 Option Exercise$19.842,48849,362181,985May 22, 2019, 06:15 PM
SABESAN VIJAYSVP, Technical OperationsMay 20, 2019 Option Exercise$19.841,47429,244149,225May 22, 2019, 06:13 PM
PITZER KENNETH RSVP, Prod Strat & Comm PlngMay 20, 2019 Option Exercise$19.842,27245,076264,378May 22, 2019, 06:11 PM
PASQUALONE FRANKSVP, Chief Comm Ops OfficerMay 20, 2019 Option Exercise$19.841,60431,823323,094May 22, 2019, 06:09 PM
HEGDE SHARATHCHANDRA SSVP, ResearchMay 20, 2019 Option Exercise$19.842,27245,076262,172May 22, 2019, 06:07 PM
HAUMANN BRETT KSVP Clin Dev & Chief Med OfcMay 20, 2019 Option Exercise$19.842,70553,667236,678May 22, 2019, 06:05 PM
BRADY ANNPresident, TBILMay 20, 2019 Option Exercise$19.841,07321,28873,257May 22, 2019, 06:03 PM
O'Connor DonalDirectorMay 16, 2019 Sale$21.001,32727,86730,244May 20, 2019, 06:02 PM
O'Connor DonalDirectorMay 17, 2019 Sale$20.192,67353,96827,571May 20, 2019, 06:02 PM
HEGDE SHARATHCHANDRA SSVP, ResearchMar 05, 2019 Sale$24.505,690139,405264,444Mar 06, 2019, 07:20 PM
HEGDE SHARATHCHANDRA SSVP, ResearchMar 04, 2019 Sale$25.063,34383,764270,134Mar 06, 2019, 07:20 PM
WORBOYS PHILIP DSVP, Translational ScienceFeb 20, 2019 Option Exercise$27.003,986107,622270,644Feb 22, 2019, 06:27 PM
Winningham Rick EChief Executive OfficerFeb 20, 2019 Option Exercise$27.0013,477363,8791,099,462Feb 22, 2019, 06:25 PM
SULIMAN SHEHNAAZSVP, Corp Dev & StrategyFeb 20, 2019 Option Exercise$27.005,763155,60197,198Feb 22, 2019, 06:23 PM
Shafer Bradford JEVP, Gen. Counsel, SecretaryFeb 20, 2019 Option Exercise$27.005,798156,546183,446Feb 22, 2019, 06:22 PM
SABESAN VIJAYSVP, Technical OperationsFeb 20, 2019 Option Exercise$27.004,568123,336149,672Feb 22, 2019, 06:20 PM
PITZER KENNETH RSVP, Prod Strat & Comm PlngFeb 20, 2019 Option Exercise$27.003,67499,198266,650Feb 22, 2019, 06:18 PM
PASQUALONE FRANKSVP, Chief Comm Ops OfficerFeb 20, 2019 Option Exercise$27.004,919132,813323,671Feb 22, 2019, 06:16 PM
HEGDE SHARATHCHANDRA SSVP, ResearchFeb 20, 2019 Option Exercise$27.003,770101,790273,477Feb 22, 2019, 06:15 PM
HAUMANN BRETT KSVP Clin Dev & Chief Med OfcFeb 20, 2019 Option Exercise$27.007,778210,006239,383Feb 22, 2019, 06:13 PM
BRADY ANNPresident, TBILFeb 20, 2019 Option Exercise$27.003,02381,62174,330Feb 22, 2019, 06:11 PM
WORBOYS PHILIP DSVP, Translational ScienceNov 20, 2018 Option Exercise$24.794,373108,407162,380Nov 21, 2018, 05:48 PM
Winningham Rick EChief Executive OfficerNov 20, 2018 Option Exercise$24.7915,557385,658795,939Nov 21, 2018, 05:47 PM
Shafer Bradford JEVP, Gen. Counsel, SecretaryNov 20, 2018 Option Exercise$24.797,006173,67976,994Nov 21, 2018, 05:46 PM
PITZER KENNETH RSVP, Prod Strat & Comm PlngNov 20, 2018 Option Exercise$24.793,90896,879158,074Nov 21, 2018, 05:45 PM
PASQUALONE FRANKSVP, Chief Comm Ops OfficerNov 20, 2018 Option Exercise$24.795,735142,171216,340Nov 21, 2018, 05:45 PM
HEGDE SHARATHCHANDRA SSVP, ResearchNov 20, 2018 Option Exercise$24.794,063100,722164,997Nov 21, 2018, 05:44 PM
HAUMANN BRETT KSVP Clin Dev & Chief Med OfcNov 20, 2018 Option Exercise$24.797,368182,653134,911Nov 21, 2018, 05:43 PM
GALA RENEE DSVP, Chief Financial OfficerNov 20, 2018 Option Exercise$24.796,697166,019157,657Nov 21, 2018, 05:42 PM
WORBOYS PHILIP DSVP, Translational ScienceSep 12, 2018 Sale$28.506,393182,201166,753Sep 14, 2018, 05:03 PM
Shafer Bradford JEVP, Gen. Counsel, SecretaryAug 27, 2018 Sale$27.717,119197,28284,000Aug 29, 2018, 06:24 PM
WORBOYS PHILIP DSVP, Translational ScienceAug 20, 2018 Option Exercise$26.955,508148,441173,146Aug 22, 2018, 07:35 PM
Winningham Rick EChief Executive OfficerAug 20, 2018 Option Exercise$26.9515,557419,261904,063Aug 22, 2018, 07:35 PM
Shafer Bradford JEVP, Gen. Counsel, SecretaryAug 20, 2018 Option Exercise$26.957,005188,78591,119Aug 22, 2018, 07:34 PM
PITZER KENNETH RSVP, Prod Strat & Comm PlngAug 20, 2018 Option Exercise$26.955,043135,909161,982Aug 22, 2018, 07:34 PM
PASQUALONE FRANKSVP, Chief Comm Ops OfficerAug 20, 2018 Option Exercise$26.955,735154,558222,075Aug 22, 2018, 07:33 PM
HEGDE SHARATHCHANDRA SSVP, ResearchAug 20, 2018 Option Exercise$26.955,198140,086169,060Aug 22, 2018, 07:33 PM
HAUMANN BRETT KSVP Clin Dev & Chief Med OfcAug 20, 2018 Option Exercise$26.956,683180,107142,279Aug 22, 2018, 07:33 PM
GALA RENEE DSVP, Chief Financial OfficerAug 20, 2018 Option Exercise$26.956,695180,430164,354Aug 22, 2018, 07:32 PM
GALA RENEE DSVP, Chief Financial OfficerAug 15, 2018 Sale$26.7441,5391,110,655172,749Aug 16, 2018, 07:08 PM
GALA RENEE DSVP, Chief Financial OfficerAug 14, 2018 Sale$27.742,20461,136212,588Aug 16, 2018, 07:08 PM
Shafer Bradford JEVP, Gen. Counsel, SecretaryAug 08, 2018 Sale$27.8525,355706,18298,124Aug 09, 2018, 07:46 PM
Shafer Bradford JEVP, Gen. Counsel, SecretaryAug 07, 2018 Sale$28.335,945168,393127,606Aug 09, 2018, 07:46 PM
Shafer Bradford JEVP, Gen. Counsel, SecretaryJun 08, 2018 Sale$23.663,90092,260129,424Jun 08, 2018, 07:34 PM
Shafer Bradford JEVP, Gen. Counsel, SecretaryJun 06, 2018 Sale$24.0910,140244,268133,324Jun 08, 2018, 07:34 PM
MALKIEL BURTON GDirectorMay 21, 2018 Buy$22.541,00022,54056,757May 23, 2018, 06:49 PM
WORBOYS PHILIP DSVP, Translational ScienceMay 20, 2018 Option Exercise$24.3119,524474,628178,654May 22, 2018, 07:03 PM
Winningham Rick EChief Executive OfficerMay 20, 2018 Option Exercise$24.3167,6171,643,769919,620May 22, 2018, 07:03 PM
Shafer Bradford JEVP, Gen. Counsel, SecretaryMay 20, 2018 Option Exercise$24.3121,812530,250143,464May 22, 2018, 07:02 PM
PITZER KENNETH RSVP, Prod Strat & Comm PlngMay 20, 2018 Option Exercise$24.3118,779456,517167,025May 22, 2018, 07:02 PM
PASQUALONE FRANKSVP, Chief Comm Ops OfficerMay 20, 2018 Option Exercise$24.3118,424447,887227,810May 22, 2018, 07:02 PM
HEGDE SHARATHCHANDRA SSVP, ResearchMay 20, 2018 Option Exercise$24.3119,103464,394174,258May 22, 2018, 07:01 PM
HAUMANN BRETT KSVP Clin Dev & Chief Med OfcMay 20, 2018 Option Exercise$24.3126,991656,151148,962May 22, 2018, 07:01 PM
GALA RENEE DSVP, Chief Financial OfficerMay 20, 2018 Option Exercise$24.3121,230516,101214,792May 22, 2018, 07:01 PM
GALA RENEE DSVP, Chief Financial OfficerMay 18, 2018 Sale$24.2910,000242,877236,022May 22, 2018, 07:01 PM
WORBOYS PHILIP DSVP, Translational ScienceFeb 20, 2018 Option Exercise$29.094,566132,825163,563Feb 22, 2018, 05:42 PM
Winningham Rick EChief Executive OfficerFeb 20, 2018 Option Exercise$29.0913,005378,315881,372Feb 22, 2018, 05:42 PM
SULIMAN SHEHNAAZSVP, Corp Dev & StrategyFeb 20, 2018 Option Exercise$29.098,770255,119101,230Feb 22, 2018, 05:41 PM
Shafer Bradford JEVP, Gen. Counsel, SecretaryFeb 20, 2018 Option Exercise$29.095,587162,526130,661Feb 22, 2018, 05:41 PM
PITZER KENNETH RSVP, Prod Strat & Comm PlngFeb 20, 2018 Option Exercise$29.094,252123,691152,054Feb 22, 2018, 05:40 PM
PASQUALONE FRANKSVP, Chief Comm Ops OfficerFeb 20, 2018 Option Exercise$29.094,741137,916211,619Feb 22, 2018, 05:40 PM
HEGDE SHARATHCHANDRA SSVP, ResearchFeb 20, 2018 Option Exercise$29.094,349126,512159,611Feb 22, 2018, 05:39 PM
HAUMANN BRETT KSVP Clin Dev & Chief Med OfcFeb 20, 2018 Option Exercise$29.098,293241,243142,203Feb 22, 2018, 05:39 PM
GALA RENEE DSVP, Chief Financial OfficerFeb 20, 2018 Option Exercise$29.095,387156,708211,407Feb 22, 2018, 05:38 PM
WORBOYS PHILIP DSVP, Translational ScienceNov 20, 2017 Option Exercise$28.585,503157,276159,129Nov 22, 2017, 04:40 PM
Shafer Bradford JEVP, Gen. Counsel, SecretaryNov 20, 2017 Option Exercise$28.587,079202,318127,248Nov 22, 2017, 04:40 PM
PITZER KENNETH RSVP, Prod Strat & Comm PlngNov 20, 2017 Option Exercise$28.585,014143,300147,306Nov 22, 2017, 04:39 PM
PASQUALONE FRANKSVP, Chief Comm Ops OfficerNov 20, 2017 Option Exercise$28.585,820166,336207,360Nov 22, 2017, 04:38 PM
HEGDE SHARATHCHANDRA SSVP, ResearchNov 20, 2017 Option Exercise$28.585,177147,959154,960Nov 22, 2017, 04:38 PM
HAUMANN BRETT KSVP Clin Dev & Chief Med OfcNov 20, 2017 Option Exercise$28.587,846224,239141,496Nov 22, 2017, 04:37 PM
GALA RENEE DSVP, Chief Financial OfficerNov 20, 2017 Option Exercise$28.586,753193,001207,794Nov 22, 2017, 04:35 PM
Shafer Bradford JEVP, Gen. Counsel, SecretarySep 06, 2017 Sale$30.7714,670451,350134,327Sep 08, 2017, 06:53 PM
PASQUALONE FRANKSVP, Chief Comm Ops OfficerAug 21, 2017 Buy$26.344,000105,359213,180Aug 23, 2017, 05:04 PM
WORBOYS PHILIP DSVP, Translational ScienceAug 20, 2017 Option Exercise$27.405,502150,755164,632Aug 22, 2017, 06:31 PM
Shafer Bradford JEVP, Gen. Counsel, SecretaryAug 20, 2017 Option Exercise$27.407,079193,965148,997Aug 22, 2017, 06:30 PM
PITZER KENNETH RSVP, Prod Strat & Comm PlngAug 20, 2017 Option Exercise$27.405,013137,356152,320Aug 22, 2017, 06:30 PM
PASQUALONE FRANKSVP, Chief Comm Ops OfficerAug 20, 2017 Option Exercise$27.405,820159,468209,180Aug 22, 2017, 06:29 PM
HEGDE SHARATHCHANDRA SSVP, ResearchAug 20, 2017 Option Exercise$27.405,176141,822160,137Aug 22, 2017, 06:28 PM
HAUMANN BRETT KSVP Clin Dev & Chief Med OfcAug 20, 2017 Option Exercise$27.407,064193,554149,342Aug 22, 2017, 06:28 PM
GALA RENEE DSVP, Chief Financial OfficerAug 20, 2017 Option Exercise$27.406,752185,005214,547Aug 22, 2017, 06:27 PM
WHITESIDES GEORGE MDirectorAug 11, 2017 Buy$24.694,00098,7644,000Aug 14, 2017, 08:00 PM
MALKIEL BURTON GDirectorAug 11, 2017 Buy$24.5915,000368,81515,000Aug 14, 2017, 07:57 PM
MALKIEL BURTON GDirectorAug 11, 2017 Buy$24.5915,000368,85447,571Aug 14, 2017, 07:57 PM
Fore HenriettaDirectorAug 11, 2017 Buy$23.996,000143,93224,000Aug 11, 2017, 06:33 PM
Winningham Rick EChief Executive OfficerAug 11, 2017 Buy$24.5010,000245,000866,377Aug 11, 2017, 06:26 PM
WORBOYS PHILIP DSVP, Translational ScienceMay 20, 2017 Option Exercise$36.835,503202,676170,134May 23, 2017, 08:01 PM
Winningham Rick EChief Executive OfficerMay 20, 2017 Option Exercise$36.8315,460569,392856,377May 23, 2017, 08:01 PM
Shafer Bradford JEVP, Gen. Counsel, SecretaryMay 20, 2017 Option Exercise$36.837,079260,720156,076May 23, 2017, 08:00 PM
PITZER KENNETH RSVP, Prod Strat & Comm PlngMay 20, 2017 Option Exercise$36.835,014184,666157,333May 23, 2017, 08:00 PM
PASQUALONE FRANKSVP, Chief Comm Ops OfficerMay 20, 2017 Option Exercise$36.835,820214,351215,000May 23, 2017, 08:00 PM
HEGDE SHARATHCHANDRA SSVP, ResearchMay 20, 2017 Option Exercise$36.835,177190,669165,313May 23, 2017, 07:59 PM
HAUMANN BRETT KSVP Clin Dev & Chief Med OfcMay 20, 2017 Option Exercise$36.837,065260,204156,406May 23, 2017, 07:59 PM
GALA RENEE DSVP, Chief Financial OfficerMay 20, 2017 Option Exercise$36.836,753248,713221,299May 23, 2017, 07:58 PM
HAUMANN BRETT KSVP Clin Dev & Chief Med OfcMar 07, 2017 Sale$30.8042413,059163,471Mar 08, 2017, 06:11 PM
HAUMANN BRETT KSVP Clin Dev & Chief Med OfcMar 06, 2017 Sale$31.5213,576427,916163,895Mar 08, 2017, 06:11 PM
Shafer Bradford JEVP, Gen. Counsel, SecretaryMar 03, 2017 Sale$31.8626,829854,772161,453Mar 07, 2017, 07:05 PM
WORBOYS PHILIP DSVP, Translational ScienceFeb 20, 2017 Option Exercise$33.7810,397351,211173,935Feb 22, 2017, 07:08 PM
Winningham Rick EChief Executive OfficerFeb 20, 2017 Option Exercise$33.7833,2641,123,658870,135Feb 22, 2017, 07:08 PM
Shafer Bradford JEVP, Gen. Counsel, SecretaryFeb 20, 2017 Option Exercise$33.7812,440420,223188,282Feb 22, 2017, 07:07 PM
PITZER KENNETH RSVP, Prod Strat & Comm PlngFeb 20, 2017 Option Exercise$33.7810,030338,813162,347Feb 22, 2017, 07:07 PM
PASQUALONE FRANKSVP Global Head Acute Care BusFeb 20, 2017 Option Exercise$33.788,762295,980219,118Feb 22, 2017, 07:07 PM
LEE JUNNINGSr. VP, Technical OperationsFeb 20, 2017 Option Exercise$33.789,611324,660225,071Feb 22, 2017, 07:06 PM
HEGDE SHARATHCHANDRA SSVP, ResearchFeb 20, 2017 Option Exercise$33.7810,138342,462170,490Feb 22, 2017, 07:06 PM
HAUMANN BRETT KSVP Clin Dev & Chief Med OfcFeb 20, 2017 Option Exercise$33.7814,434487,581177,471Feb 22, 2017, 07:06 PM
GALA RENEE DSVP, Chief Financial OfficerFeb 20, 2017 Option Exercise$33.7810,211344,928226,350Feb 22, 2017, 07:05 PM
WORBOYS PHILIP DSVP, Translational ScienceNov 20, 2016 Option Exercise$31.962,10467,244175,332Nov 22, 2016, 06:07 PM
Winningham Rick EChief Executive OfficerNov 20, 2016 Option Exercise$31.968,360267,186875,399Nov 22, 2016, 06:06 PM
Shafer Bradford JEVP, Gen. Counsel, SecretaryNov 20, 2016 Option Exercise$31.964,008128,096191,722Nov 22, 2016, 06:04 PM
PITZER KENNETH RSVP, Prod Strat & Comm PlngNov 20, 2016 Option Exercise$31.961,72755,195163,377Nov 22, 2016, 06:04 PM
LEE JUNNINGSr. VP, Technical OperationsNov 20, 2016 Option Exercise$31.963,785120,969234,682Nov 22, 2016, 06:03 PM
HEGDE SHARATHCHANDRA SSVP, ResearchNov 20, 2016 Option Exercise$31.961,84558,966171,628Nov 22, 2016, 06:03 PM
HAUMANN BRETT KSVP Clin Dev & Chief Med OfcNov 20, 2016 Option Exercise$31.965,388172,200182,905Nov 22, 2016, 06:02 PM
GALA RENEE DSVP, Chief Financial OfficerNov 20, 2016 Option Exercise$31.964,628147,911227,561Nov 22, 2016, 06:01 PM
HAUMANN BRETT KSVP Clin Dev & Chief Med OfcAug 25, 2016 Sale$27.994,491125,703188,293Aug 25, 2016, 07:34 PM
WORBOYS PHILIP DSVP, Translational ScienceAug 20, 2016 Option Exercise$27.892,10458,681177,436Aug 23, 2016, 07:26 PM
PITZER KENNETH RSVP, Prod Strat & Comm PlngAug 20, 2016 Option Exercise$27.891,72948,222165,104Aug 23, 2016, 07:25 PM
LEE JUNNINGSr. VP, Technical OperationsAug 20, 2016 Option Exercise$27.893,785105,564238,467Aug 23, 2016, 07:24 PM
HEGDE SHARATHCHANDRA SSVP, ResearchAug 20, 2016 Option Exercise$27.891,84651,485173,473Aug 23, 2016, 07:23 PM
HAUMANN BRETT KSVP Clin Dev & Chief Med OfcAug 20, 2016 Option Exercise$27.894,607128,489192,784Aug 23, 2016, 07:23 PM
HAUMANN BRETT KSVP Clin Dev & Chief Med OfcAug 19, 2016 Sale$27.979,509265,967197,391Aug 23, 2016, 07:23 PM
GALA RENEE DSVP, Chief Financial OfficerAug 20, 2016 Option Exercise$27.894,306120,094232,189Aug 23, 2016, 07:22 PM
Shafer Bradford JEVP, Gen. Counsel, SecretaryAug 20, 2016 Option Exercise$27.894,008111,783232,808Aug 22, 2016, 07:08 PM
Shafer Bradford JEVP, Gen. Counsel, SecretaryAug 22, 2016 Sale$27.1637,0781,007,038195,730Aug 22, 2016, 07:08 PM
Shafer Bradford JEVP, Gen. Counsel, SecretaryAug 19, 2016 Sale$28.144,870137,042236,816Aug 22, 2016, 07:08 PM
Shafer Bradford JEVP, Gen. Counsel, SecretaryAug 18, 2016 Sale$28.557,174204,818241,686Aug 22, 2016, 07:08 PM
WORBOYS PHILIP DSVP, Translational ScienceMay 20, 2016 Option Exercise$20.552,10543,258179,540May 24, 2016, 08:01 PM
Shafer Bradford JEVP, Gen. Counsel, SecretaryMay 20, 2016 Option Exercise$20.554,00882,364248,860May 24, 2016, 08:00 PM
PITZER KENNETH RSVP, Prod Strat & Comm PlngMay 20, 2016 Option Exercise$20.551,72835,510166,833May 24, 2016, 08:00 PM
LEE JUNNINGSr. VP, Technical OperationsMay 20, 2016 Option Exercise$20.553,78577,782242,252May 24, 2016, 07:59 PM
HEGDE SHARATHCHANDRA SSVP, ResearchMay 20, 2016 Option Exercise$20.551,84637,935175,319May 24, 2016, 07:59 PM
HAUMANN BRETT KSVP Clin Dev & Chief Med OfcMay 20, 2016 Option Exercise$20.554,60894,694206,900May 24, 2016, 07:59 PM
GALA RENEE DSVP, Chief Financial OfficerMay 20, 2016 Option Exercise$20.553,33368,493236,495May 24, 2016, 07:58 PM
GLAXOSMITHKLINE PLC10% OwnerMar 14, 2016 Buy$23028000.001,301,01529,959,773,420,0009,644,807Mar 15, 2016, 04:31 PM
Shafer Bradford JSr VP, Gen. Counsel, SecretaryFeb 20, 2016 Option Exercise$15.6518,920296,098136,165Feb 23, 2016, 07:59 PM
GALA RENEE DSVP, Chief Financial OfficerFeb 20, 2016 Option Exercise$15.6513,052204,264148,125Feb 23, 2016, 07:58 PM
Mammen MathaiSVP, Research & DevelopmentFeb 20, 2016 Option Exercise$15.6519,844310,559198,111Feb 23, 2016, 07:58 PM
LEE JUNNINGSr. VP, Technical OperationsFeb 20, 2016 Option Exercise$15.6516,049251,167154,335Feb 23, 2016, 07:57 PM
HAUMANN BRETT KSVP, Clinical DevelopmentFeb 20, 2016 Option Exercise$15.6518,425288,351121,508Feb 23, 2016, 07:56 PM
BLUM LEONARD MSr VP, Chief Comm. OfficerFeb 20, 2016 Option Exercise$15.6516,101251,981182,731Feb 23, 2016, 07:56 PM
PASQUALONE FRANKSr. VP, OperationsFeb 20, 2016 Option Exercise$15.6510,830169,489127,178Feb 23, 2016, 07:55 PM
Shafer Bradford JSr VP, Gen. Counsel, SecretaryNov 20, 2015 Option Exercise$17.1793416,037155,085Nov 24, 2015, 07:37 PM
Mammen MathaiSVP, Research & DevelopmentNov 20, 2015 Option Exercise$17.1793416,037217,955Nov 24, 2015, 07:37 PM
LEE JUNNINGSr. VP, Technical OperationsNov 20, 2015 Option Exercise$17.171,03717,805170,384Nov 24, 2015, 07:36 PM
HAUMANN BRETT KSVP, Clinical DevelopmentNov 20, 2015 Option Exercise$17.1778113,410139,933Nov 24, 2015, 07:36 PM
GLAXOSMITHKLINE PLC10% OwnerOct 07, 2015 Buy$607544.0044,57427,080,666,2568,343,792Oct 07, 2015, 04:31 PM
Mammen MathaiSVP, Research & DevelopmentAug 20, 2015 Option Exercise$12.9893412,123218,889Aug 24, 2015, 07:11 PM
BLUM LEONARD MSr VP, Chief Comm. OfficerAug 20, 2015 Option Exercise$12.9893412,123198,832Aug 24, 2015, 07:11 PM
Shafer Bradford JSr VP, Gen. Counsel, SecretaryAug 20, 2015 Option Exercise$12.9893412,123156,019Aug 24, 2015, 07:10 PM
LEE JUNNINGSr. VP, Technical OperationsAug 18, 2015 Buy$12.909,000116,1009,000Aug 18, 2015, 08:30 PM
MALKIEL BURTON GDirectorAug 18, 2015 Buy$12.9210,000129,20020,571Aug 18, 2015, 08:26 PM
GALA RENEE DSVP, Chief Financial OfficerAug 17, 2015 Buy$12.165,00060,800161,177Aug 17, 2015, 07:21 PM
GALA RENEE DSVP, Chief Financial OfficerAug 13, 2015 Buy$12.195,00060,950154,279Aug 17, 2015, 07:21 PM
Winningham Rick EChief Executive OfficerAug 17, 2015 Buy$12.1316,860204,512602,056Aug 17, 2015, 07:21 PM
Winningham Rick EChief Executive OfficerAug 14, 2015 Buy$11.7963,140744,421583,298Aug 17, 2015, 07:21 PM
Shafer Bradford JSr VP, Gen. Counsel, SecretaryJun 02, 2015 Option Exercise$13.837,360101,789156,953Jun 04, 2015, 07:14 PM
Mammen MathaiSVP, Research & DevelopmentJun 02, 2015 Option Exercise$13.837,360101,789219,823Jun 04, 2015, 07:14 PM
LEE JUNNINGSr. VP, Technical OperationsJun 02, 2015 Option Exercise$13.835,15271,252169,720Jun 04, 2015, 07:13 PM
BLUM LEONARD MSr VP, Chief Comm. OfficerJun 02, 2015 Option Exercise$13.837,360101,789199,766Jun 04, 2015, 07:13 PM
Shafer Bradford JSr VP, Gen. Counsel, SecretaryMay 20, 2015 Option Exercise$14.246739,584164,313May 22, 2015, 07:16 PM
LEE JUNNINGSr. VP, Technical OperationsMay 20, 2015 Option Exercise$14.2474810,652174,872May 22, 2015, 07:16 PM
BLUM LEONARD MSr VP, Chief Comm. OfficerMay 20, 2015 Option Exercise$14.246739,584207,126May 22, 2015, 07:13 PM
Mammen MathaiSVP, Research & DevelopmentMay 20, 2015 Option Exercise$14.246739,584227,183May 22, 2015, 07:13 PM
Shafer Bradford JSr VP, Gen. Counsel, SecretaryFeb 20, 2015 Option Exercise$19.5267413,156163,088Feb 24, 2015, 06:55 PM
Mammen MathaiSVP, Research & DevelopmentFeb 20, 2015 Option Exercise$19.5267413,156227,856Feb 24, 2015, 06:55 PM
LEE JUNNINGSr. VP, Technical OperationsFeb 20, 2015 Option Exercise$19.5297018,934175,620Feb 24, 2015, 06:54 PM
BLUM LEONARD MSr VP, Chief Comm. OfficerFeb 20, 2015 Option Exercise$19.5267413,156207,799Feb 24, 2015, 06:54 PM
Winningham Rick EChief Executive OfficerFeb 20, 2015 Option Exercise$19.521,48028,890520,158Feb 24, 2015, 06:53 PM
GALA RENEE DSVP-FinanceAug 20, 2014 Option Exercise$26.981584,26314,279Aug 22, 2014, 05:01 PM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
Winningham Rick ECHIEF EXECUTIVE OFFICER03/15/202423,363
Winningham Rick ECHIEF EXECUTIVE OFFICER02/20/2024331,788
Sawaf AzizSVP & CHIEF FINANCIAL OFFICER02/20/2024151,961
Miller AineSVP, DEV & HEAD OF IRE OFFICE02/20/2024105,095
Grimaud Brett A.SVP, GEN COUNSEL AND SECRETARY02/20/2024156,947
GRAHAM RICHARD ASVP, RESEARCH & DEVELOPMENT02/20/2024172,102
Farnum RhondaSVP, COMM & MEDICAL AFFAIRS02/20/2024162,513
Farnum RhondaSVP, COMM & MEDICAL AFFAIRS02/22/202410,922
Winningham Rick ECHIEF EXECUTIVE OFFICER11/20/2023163,887
Sawaf AzizSVP & CHIEF FINANCIAL OFFICER11/20/202364,159
Grimaud Brett A.SVP, GEN COUNSEL AND SECRETARY11/20/202376,354
GRAHAM RICHARD ASVP, RESEARCH & DEVELOPMENT11/20/2023130,973
Farnum RhondaSVP, COMM & MEDICAL AFFAIRS11/20/202382,773
Farnum RhondaSVP, COMM & MEDICAL AFFAIRS11/21/202314,180
GRAHAM RICHARD ASVP, RESEARCH & DEVELOPMENT11/14/202325,366
GRAHAM RICHARD ASVP, RESEARCH & DEVELOPMENT10/16/202322,412
GRAHAM RICHARD ASVP, RESEARCH & DEVELOPMENT09/14/202324,547
Farnum RhondaSVP, COMM & MEDICAL AFFAIRS08/22/202317,112
Winningham Rick ECHIEF EXECUTIVE OFFICER08/20/2023153,299
Sawaf AzizSVP & CHIEF FINANCIAL OFFICER08/20/202369,006
Grimaud Brett A.SVP, GEN COUNSEL AND SECRETARY08/20/202386,446
GRAHAM RICHARD ASVP, RESEARCH & DEVELOPMENT08/20/2023101,472
Farnum RhondaSVP, COMM & MEDICAL AFFAIRS08/20/2023101,462
GRAHAM RICHARD ASVP, RESEARCH & DEVELOPMENT08/11/202323,197
GRAHAM RICHARD ASVP, RESEARCH & DEVELOPMENT07/14/202322,848
GRAHAM RICHARD ASVP, RESEARCH & DEVELOPMENT06/14/202324,822
Farnum RhondaSVP, COMM & MEDICAL AFFAIRS06/08/202319,923
Winningham Rick ECHIEF EXECUTIVE OFFICER05/20/2023177,163
Sawaf AzizSVP & CHIEF FINANCIAL OFFICER05/20/202398,020
Grimaud Brett A.SVP, GEN COUNSEL AND SECRETARY05/20/2023128,567
GRAHAM RICHARD ASVP, RESEARCH & DEVELOPMENT05/20/2023117,257
Farnum RhondaSVP, COMM & MEDICAL AFFAIRS05/20/202362,406
GRAHAM RICHARD ASVP, RESEARCH & DEVELOPMENT05/15/202326,146
GRAHAM RICHARD ASVP, RESEARCH & DEVELOPMENT04/14/202327,597
GRAHAM RICHARD ASVP, RESEARCH & DEVELOPMENT03/14/202323,973
Farnum RhondaSVP, COMM & MEDICAL AFFAIRS03/09/202340,800
GRAHAM RICHARD ASVP, RESEARCH & DEVELOPMENT03/06/202323,346
Winningham Rick ECHIEF EXECUTIVE OFFICER02/20/2023390,665
Sawaf AzizSVP & CHIEF FINANCIAL OFFICER02/20/202370,815
Grimaud Brett A.SVP, GEN COUNSEL AND SECRETARY02/20/2023106,467
GRAHAM RICHARD ASVP, RESEARCH & DEVELOPMENT02/20/2023125,875
Farnum RhondaSVP, COMM & MEDICAL AFFAIRS02/20/202374,322
Winningham Rick ECHIEF EXECUTIVE OFFICER12/14/2022559,500
GRAHAM RICHARD ASVP, RESEARCH & DEVELOPMENT12/01/202222,361
O'Connor DonalDirector11/22/2022105,000
Winningham Rick ECHIEF EXECUTIVE OFFICER11/20/2022171,473
Hindman Andrew A.SVP, CHIEF FINANCIAL OFFICER11/20/2022271,868
Hindman Andrew A.SVP, CHIEF FINANCIAL OFFICER11/18/2022716,242
GRAHAM RICHARD ASVP, RESEARCH & DEVELOPMENT11/20/2022296,748
Farnum RhondaSVP, COMM & MEDICAL AFFAIRS11/20/2022252,458
GRAHAM RICHARD ASVP, RESEARCH & DEVELOPMENT11/16/202231,360
GSK PLCFormer 10% Owner09/16/202294,036,868
Winningham Rick ECHIEF EXECUTIVE OFFICER08/19/2022147,609
Hindman Andrew A.SVP, CHIEF FINANCIAL OFFICER08/19/2022239,814
GRAHAM RICHARD ASVP, DEVELOPMENT08/19/2022177,376
Farnum RhondaSVP, COMM & MEDICAL AFFAIRS08/19/202297,257
GRAHAM RICHARD ASVP, DEVELOPMENT08/16/202247,640
GRAHAM RICHARD ASVP, DEVELOPMENT08/09/2022132,606
Winningham Rick ECHIEF EXECUTIVE OFFICER05/20/202296,358
Hindman Andrew A.SVP, CHIEF FINANCIAL OFFICER05/20/202229,410
GRAHAM RICHARD ASVP, DEVELOPMENT05/20/202234,497
Farnum RhondaSVP, COMM & MEDICAL AFFAIRS05/20/202219,228
Farnum RhondaSVP, COMM & MEDICAL AFFAIRS05/23/20229,653
Farnum RhondaSVP, COMM & MEDICAL AFFAIRS02/28/202223,947
Winningham Rick ECHIEF EXECUTIVE OFFICER02/18/2022218,243
PITZER KENNETH RSVP, PROD STRAT & COMM PLNG02/18/2022262,343
Hindman Andrew A.SVP, CHIEF FINANCIAL OFFICER02/18/2022249,601
GRAHAM RICHARD ASVP, DEVELOPMENT02/18/2022195,823
Farnum RhondaSVP, COMM & MEDICAL AFFAIRS02/18/2022113,629
BRADY ANNPRESIDENT, TBIL02/18/202280,426
BRADY ANNPRESIDENT, TBIL11/19/202126,493
PASQUALONE FRANKSVP, CHIEF BUSINESS OFFICER11/19/202131,592
PITZER KENNETH RSVP, PROD STRAT & COMM PLNG11/19/202136,032
GRAHAM RICHARD ASVP, DEVELOPMENT11/19/202135,639
Hindman Andrew A.SVP, CHIEF FINANCIAL OFFICER11/19/202111,286
WORBOYS PHILIP DSVP, RESEARCH & TRANSL SCIENCE11/19/202136,032
SABESAN VIJAYSVP, TECHNICAL OPERATIONS11/19/202143,397
Winningham Rick ECHIEF EXECUTIVE OFFICER11/19/202195,337
WORBOYS PHILIP DSVP, Research & Transl Science08/20/202160,513
Winningham Rick EChief Executive Officer08/20/2021160,226
Shafer Bradford JEVP, Gen. Counsel, Secretary08/20/202160,513
SABESAN VIJAYSVP, Technical Operations08/20/202172,962
PITZER KENNETH RSVP, Prod Strat & Comm Plng08/20/202160,513
PASQUALONE FRANKSVP, Chief Business Officer08/20/202153,095
Hindman Andrew A.SVP, Chief Financial Officer08/20/2021245,369
GRAHAM RICHARD ASVP, Development08/20/202195,807
BRADY ANNPresident, TBIL08/20/202144,524
Winningham Rick EChief Executive Officer05/20/2021202,991
Shafer Bradford JEVP, Gen. Counsel, Secretary05/20/202176,718
GRAHAM RICHARD ASVP, Development05/20/202160,698
BRADY ANNPresident, TBIL05/20/202156,408
WORBOYS PHILIP DSVP, Research & Transl Science03/09/2021176,580
WORBOYS PHILIP DSVP, Research & Transl Science02/20/2021599,157
Winningham Rick EChief Executive Officer02/20/20212,073,439
Shafer Bradford JEVP, Gen. Counsel, Secretary02/20/2021598,819
SABESAN VIJAYSVP, Technical Operations02/20/2021156,765
PITZER KENNETH RSVP, Prod Strat & Comm Plng02/20/2021599,984
PASQUALONE FRANKSVP, Chief Business Officer02/20/2021506,597
Hindman Andrew A.SVP, Chief Financial Officer02/20/202174,859
HAUMANN BRETT KChief Medical Officer02/20/2021670,277
GRAHAM RICHARD ASVP, Development02/20/2021123,958
BRADY ANNPresident, TBIL02/20/2021189,629
GRAHAM RICHARD ASVP, Development12/14/2020146,058
WORBOYS PHILIP DSVP, Research & Transl Science12/03/202076,428
WORBOYS PHILIP DSVP, Research & Transl Science11/20/202082,728
Winningham Rick EChief Executive Officer11/20/2020240,011
Shafer Bradford JEVP, Gen. Counsel, Secretary11/20/202082,728
SABESAN VIJAYSVP, Technical Operations11/20/202065,364
PITZER KENNETH RSVP, Prod Strat & Comm Plng11/20/202082,728
PASQUALONE FRANKSVP, Chief Comm Ops Officer11/20/202072,523
HAUMANN BRETT KChief Medical Officer11/20/202079,837
GRAHAM RICHARD ASVP, Development11/20/202066,706
BRADY ANNPresident, TBIL11/20/202039,445
WORBOYS PHILIP DSVP, Research & Transl Science08/20/202087,529
WORBOYS PHILIP DSVP, Research & Transl Science08/20/2020307,854
Winningham Rick EChief Executive Officer08/20/2020254,096
Shafer Bradford JEVP, Gen. Counsel, Secretary08/20/202087,529
SABESAN VIJAYSVP, Technical Operations08/20/202069,218
PITZER KENNETH RSVP, Prod Strat & Comm Plng08/20/202087,529
PASQUALONE FRANKSVP, Chief Comm Ops Officer08/20/202076,779
Hindman Andrew A.SVP, Chief Financial Officer08/20/202078,765
HAUMANN BRETT KChief Medical Officer08/20/202084,650
HAUMANN BRETT KChief Medical Officer08/21/2020457,240
GRAHAM RICHARD ASVP, Development08/20/2020120,216
BRADY ANNPresident, TBIL08/20/202041,760
WORBOYS PHILIP DSVP, Research & Transl Science05/20/2020128,203
Winningham Rick EChief Executive Officer05/20/2020371,940
Shafer Bradford JEVP, Gen. Counsel, Secretary05/20/2020128,203
SABESAN VIJAYSVP, Technical Operations05/20/2020101,373
PITZER KENNETH RSVP, Prod Strat & Comm Plng05/20/2020128,203
PASQUALONE FRANKSVP, Chief Comm Ops Officer05/20/2020112,387
HAUMANN BRETT KSVP Clin Dev & Chief Med Ofc05/20/2020112,334
BRADY ANNPresident, TBIL05/20/202061,128
WORBOYS PHILIP DSVP, Research & Transl Science02/20/2020753,819
Winningham Rick EChief Executive Officer02/20/20202,508,415
Shafer Bradford JEVP, Gen. Counsel, Secretary02/20/2020761,512
SABESAN VIJAYSVP, Technical Operations02/20/2020186,817
PITZER KENNETH RSVP, Prod Strat & Comm Plng02/20/2020754,622
PASQUALONE FRANKSVP, Chief Comm Ops Officer02/20/2020631,753
Hindman Andrew A.SVP, Chief Financial Officer02/20/2020182,854
HAUMANN BRETT KSVP Clin Dev & Chief Med Ofc02/20/2020870,447
BRADY ANNPresident, TBIL02/20/2020154,053
SABESAN VIJAYSVP, Technical Operations12/12/201921,598
WORBOYS PHILIP DSVP, Research & Transl Science11/20/201939,987
Winningham Rick EChief Executive Officer11/20/2019152,733
Shafer Bradford JEVP, Gen. Counsel, Secretary11/20/201962,779
SABESAN VIJAYSVP, Technical Operations11/20/201925,925
PITZER KENNETH RSVP, Prod Strat & Comm Plng11/20/201939,987
PASQUALONE FRANKSVP, Chief Comm Ops Officer11/20/201943,067
HAUMANN BRETT KSVP Clin Dev & Chief Med Ofc11/20/201947,379
BRADY ANNPresident, TBIL11/20/201918,885
WORBOYS PHILIP DSVP, Translational Science08/20/201948,871
Winningham Rick EChief Executive Officer08/20/2019186,664
Shafer Bradford JEVP, Gen. Counsel, Secretary08/20/201966,337
SABESAN VIJAYSVP, Technical Operations08/20/201931,663
PITZER KENNETH RSVP, Prod Strat & Comm Plng08/20/201948,871
PASQUALONE FRANKSVP, Chief Comm Ops Officer08/20/201950,226
HEGDE SHARATHCHANDRA SSVP, Research08/20/201948,871
HAUMANN BRETT KSVP Clin Dev & Chief Med Ofc08/20/201958,292
BRADY ANNPresident, TBIL08/20/201923,080
WORBOYS PHILIP DSVP, Translational Science05/20/201945,076
Winningham Rick EChief Executive Officer05/20/2019172,172
Shafer Bradford JEVP, Gen. Counsel, Secretary05/20/201949,362
SABESAN VIJAYSVP, Technical Operations05/20/201929,244
PITZER KENNETH RSVP, Prod Strat & Comm Plng05/20/201945,076
PASQUALONE FRANKSVP, Chief Comm Ops Officer05/20/201931,823
HEGDE SHARATHCHANDRA SSVP, Research05/20/201945,076
HAUMANN BRETT KSVP Clin Dev & Chief Med Ofc05/20/201953,667
BRADY ANNPresident, TBIL05/20/201921,288
O'Connor DonalDirector05/16/201927,867
O'Connor DonalDirector05/17/201953,968
HEGDE SHARATHCHANDRA SSVP, Research03/05/2019139,405
HEGDE SHARATHCHANDRA SSVP, Research03/04/201983,764
WORBOYS PHILIP DSVP, Translational Science02/20/2019107,622
Winningham Rick EChief Executive Officer02/20/2019363,879
SULIMAN SHEHNAAZSVP, Corp Dev & Strategy02/20/2019155,601
Shafer Bradford JEVP, Gen. Counsel, Secretary02/20/2019156,546
SABESAN VIJAYSVP, Technical Operations02/20/2019123,336
PITZER KENNETH RSVP, Prod Strat & Comm Plng02/20/201999,198
PASQUALONE FRANKSVP, Chief Comm Ops Officer02/20/2019132,813
HEGDE SHARATHCHANDRA SSVP, Research02/20/2019101,790
HAUMANN BRETT KSVP Clin Dev & Chief Med Ofc02/20/2019210,006
BRADY ANNPresident, TBIL02/20/201981,621
WORBOYS PHILIP DSVP, Translational Science11/20/2018108,407
Winningham Rick EChief Executive Officer11/20/2018385,658
Shafer Bradford JEVP, Gen. Counsel, Secretary11/20/2018173,679
PITZER KENNETH RSVP, Prod Strat & Comm Plng11/20/201896,879
PASQUALONE FRANKSVP, Chief Comm Ops Officer11/20/2018142,171
HEGDE SHARATHCHANDRA SSVP, Research11/20/2018100,722
HAUMANN BRETT KSVP Clin Dev & Chief Med Ofc11/20/2018182,653
GALA RENEE DSVP, Chief Financial Officer11/20/2018166,019
WORBOYS PHILIP DSVP, Translational Science09/12/2018182,201
Shafer Bradford JEVP, Gen. Counsel, Secretary08/27/2018197,282
WORBOYS PHILIP DSVP, Translational Science08/20/2018148,441
Winningham Rick EChief Executive Officer08/20/2018419,261
Shafer Bradford JEVP, Gen. Counsel, Secretary08/20/2018188,785
PITZER KENNETH RSVP, Prod Strat & Comm Plng08/20/2018135,909
PASQUALONE FRANKSVP, Chief Comm Ops Officer08/20/2018154,558
HEGDE SHARATHCHANDRA SSVP, Research08/20/2018140,086
HAUMANN BRETT KSVP Clin Dev & Chief Med Ofc08/20/2018180,107
GALA RENEE DSVP, Chief Financial Officer08/20/2018180,430
GALA RENEE DSVP, Chief Financial Officer08/15/20181,110,655
GALA RENEE DSVP, Chief Financial Officer08/14/201861,136
Shafer Bradford JEVP, Gen. Counsel, Secretary08/08/2018706,182
Shafer Bradford JEVP, Gen. Counsel, Secretary08/07/2018168,393
Shafer Bradford JEVP, Gen. Counsel, Secretary06/08/201892,260
Shafer Bradford JEVP, Gen. Counsel, Secretary06/06/2018244,268
MALKIEL BURTON GDirector05/21/201822,540
WORBOYS PHILIP DSVP, Translational Science05/20/2018474,628
Winningham Rick EChief Executive Officer05/20/20181,643,769
Shafer Bradford JEVP, Gen. Counsel, Secretary05/20/2018530,250
PITZER KENNETH RSVP, Prod Strat & Comm Plng05/20/2018456,517
PASQUALONE FRANKSVP, Chief Comm Ops Officer05/20/2018447,887
HEGDE SHARATHCHANDRA SSVP, Research05/20/2018464,394
HAUMANN BRETT KSVP Clin Dev & Chief Med Ofc05/20/2018656,151
GALA RENEE DSVP, Chief Financial Officer05/20/2018516,101
GALA RENEE DSVP, Chief Financial Officer05/18/2018242,877
WORBOYS PHILIP DSVP, Translational Science02/20/2018132,825
Winningham Rick EChief Executive Officer02/20/2018378,315
SULIMAN SHEHNAAZSVP, Corp Dev & Strategy02/20/2018255,119
Shafer Bradford JEVP, Gen. Counsel, Secretary02/20/2018162,526
PITZER KENNETH RSVP, Prod Strat & Comm Plng02/20/2018123,691
PASQUALONE FRANKSVP, Chief Comm Ops Officer02/20/2018137,916
HEGDE SHARATHCHANDRA SSVP, Research02/20/2018126,512
HAUMANN BRETT KSVP Clin Dev & Chief Med Ofc02/20/2018241,243
GALA RENEE DSVP, Chief Financial Officer02/20/2018156,708
WORBOYS PHILIP DSVP, Translational Science11/20/2017157,276
Shafer Bradford JEVP, Gen. Counsel, Secretary11/20/2017202,318
PITZER KENNETH RSVP, Prod Strat & Comm Plng11/20/2017143,300
PASQUALONE FRANKSVP, Chief Comm Ops Officer11/20/2017166,336
HEGDE SHARATHCHANDRA SSVP, Research11/20/2017147,959
HAUMANN BRETT KSVP Clin Dev & Chief Med Ofc11/20/2017224,239
GALA RENEE DSVP, Chief Financial Officer11/20/2017193,001
Shafer Bradford JEVP, Gen. Counsel, Secretary09/06/2017451,350
PASQUALONE FRANKSVP, Chief Comm Ops Officer08/21/2017105,359
WORBOYS PHILIP DSVP, Translational Science08/20/2017150,755
Shafer Bradford JEVP, Gen. Counsel, Secretary08/20/2017193,965
PITZER KENNETH RSVP, Prod Strat & Comm Plng08/20/2017137,356
PASQUALONE FRANKSVP, Chief Comm Ops Officer08/20/2017159,468
HEGDE SHARATHCHANDRA SSVP, Research08/20/2017141,822
HAUMANN BRETT KSVP Clin Dev & Chief Med Ofc08/20/2017193,554
GALA RENEE DSVP, Chief Financial Officer08/20/2017185,005
WHITESIDES GEORGE MDirector08/11/201798,764
MALKIEL BURTON GDirector08/11/2017368,815
MALKIEL BURTON GDirector08/11/2017368,854
Fore HenriettaDirector08/11/2017143,932
Winningham Rick EChief Executive Officer08/11/2017245,000
WORBOYS PHILIP DSVP, Translational Science05/20/2017202,676
Winningham Rick EChief Executive Officer05/20/2017569,392
Shafer Bradford JEVP, Gen. Counsel, Secretary05/20/2017260,720
PITZER KENNETH RSVP, Prod Strat & Comm Plng05/20/2017184,666
PASQUALONE FRANKSVP, Chief Comm Ops Officer05/20/2017214,351
HEGDE SHARATHCHANDRA SSVP, Research05/20/2017190,669
HAUMANN BRETT KSVP Clin Dev & Chief Med Ofc05/20/2017260,204
GALA RENEE DSVP, Chief Financial Officer05/20/2017248,713
HAUMANN BRETT KSVP Clin Dev & Chief Med Ofc03/07/201713,059
HAUMANN BRETT KSVP Clin Dev & Chief Med Ofc03/06/2017427,916
Shafer Bradford JEVP, Gen. Counsel, Secretary03/03/2017854,772
WORBOYS PHILIP DSVP, Translational Science02/20/2017351,211
Winningham Rick EChief Executive Officer02/20/20171,123,658
Shafer Bradford JEVP, Gen. Counsel, Secretary02/20/2017420,223
PITZER KENNETH RSVP, Prod Strat & Comm Plng02/20/2017338,813
PASQUALONE FRANKSVP Global Head Acute Care Bus02/20/2017295,980
LEE JUNNINGSr. VP, Technical Operations02/20/2017324,660
HEGDE SHARATHCHANDRA SSVP, Research02/20/2017342,462
HAUMANN BRETT KSVP Clin Dev & Chief Med Ofc02/20/2017487,581
GALA RENEE DSVP, Chief Financial Officer02/20/2017344,928
WORBOYS PHILIP DSVP, Translational Science11/20/201667,244
Winningham Rick EChief Executive Officer11/20/2016267,186
Shafer Bradford JEVP, Gen. Counsel, Secretary11/20/2016128,096
PITZER KENNETH RSVP, Prod Strat & Comm Plng11/20/201655,195
LEE JUNNINGSr. VP, Technical Operations11/20/2016120,969
HEGDE SHARATHCHANDRA SSVP, Research11/20/201658,966
HAUMANN BRETT KSVP Clin Dev & Chief Med Ofc11/20/2016172,200
GALA RENEE DSVP, Chief Financial Officer11/20/2016147,911
HAUMANN BRETT KSVP Clin Dev & Chief Med Ofc08/25/2016125,703
WORBOYS PHILIP DSVP, Translational Science08/20/201658,681
PITZER KENNETH RSVP, Prod Strat & Comm Plng08/20/201648,222
LEE JUNNINGSr. VP, Technical Operations08/20/2016105,564
HEGDE SHARATHCHANDRA SSVP, Research08/20/201651,485
HAUMANN BRETT KSVP Clin Dev & Chief Med Ofc08/20/2016128,489
HAUMANN BRETT KSVP Clin Dev & Chief Med Ofc08/19/2016265,967
GALA RENEE DSVP, Chief Financial Officer08/20/2016120,094
Shafer Bradford JEVP, Gen. Counsel, Secretary08/20/2016111,783
Shafer Bradford JEVP, Gen. Counsel, Secretary08/22/20161,007,038
Shafer Bradford JEVP, Gen. Counsel, Secretary08/19/2016137,042
Shafer Bradford JEVP, Gen. Counsel, Secretary08/18/2016204,818
WORBOYS PHILIP DSVP, Translational Science05/20/201643,258
Shafer Bradford JEVP, Gen. Counsel, Secretary05/20/201682,364
PITZER KENNETH RSVP, Prod Strat & Comm Plng05/20/201635,510
LEE JUNNINGSr. VP, Technical Operations05/20/201677,782
HEGDE SHARATHCHANDRA SSVP, Research05/20/201637,935
HAUMANN BRETT KSVP Clin Dev & Chief Med Ofc05/20/201694,694
GALA RENEE DSVP, Chief Financial Officer05/20/201668,493
GLAXOSMITHKLINE PLC10% Owner03/14/201629,959,773,420,000
Shafer Bradford JSr VP, Gen. Counsel, Secretary02/20/2016296,098
GALA RENEE DSVP, Chief Financial Officer02/20/2016204,264
Mammen MathaiSVP, Research & Development02/20/2016310,559
LEE JUNNINGSr. VP, Technical Operations02/20/2016251,167
HAUMANN BRETT KSVP, Clinical Development02/20/2016288,351
BLUM LEONARD MSr VP, Chief Comm. Officer02/20/2016251,981
PASQUALONE FRANKSr. VP, Operations02/20/2016169,489
Shafer Bradford JSr VP, Gen. Counsel, Secretary11/20/201516,037
Mammen MathaiSVP, Research & Development11/20/201516,037
LEE JUNNINGSr. VP, Technical Operations11/20/201517,805
HAUMANN BRETT KSVP, Clinical Development11/20/201513,410
GLAXOSMITHKLINE PLC10% Owner10/07/201527,080,666,256
Mammen MathaiSVP, Research & Development08/20/201512,123
BLUM LEONARD MSr VP, Chief Comm. Officer08/20/201512,123
Shafer Bradford JSr VP, Gen. Counsel, Secretary08/20/201512,123
LEE JUNNINGSr. VP, Technical Operations08/18/2015116,100
MALKIEL BURTON GDirector08/18/2015129,200
GALA RENEE DSVP, Chief Financial Officer08/17/201560,800
GALA RENEE DSVP, Chief Financial Officer08/13/201560,950
Winningham Rick EChief Executive Officer08/17/2015204,512
Winningham Rick EChief Executive Officer08/14/2015744,421
Shafer Bradford JSr VP, Gen. Counsel, Secretary06/02/2015101,789
Mammen MathaiSVP, Research & Development06/02/2015101,789
LEE JUNNINGSr. VP, Technical Operations06/02/201571,252
BLUM LEONARD MSr VP, Chief Comm. Officer06/02/2015101,789
Shafer Bradford JSr VP, Gen. Counsel, Secretary05/20/20159,584
LEE JUNNINGSr. VP, Technical Operations05/20/201510,652
BLUM LEONARD MSr VP, Chief Comm. Officer05/20/20159,584
Mammen MathaiSVP, Research & Development05/20/20159,584
Shafer Bradford JSr VP, Gen. Counsel, Secretary02/20/201513,156
Mammen MathaiSVP, Research & Development02/20/201513,156
LEE JUNNINGSr. VP, Technical Operations02/20/201518,934
BLUM LEONARD MSr VP, Chief Comm. Officer02/20/201513,156
Winningham Rick EChief Executive Officer02/20/201528,890
GALA RENEE DSVP-Finance08/20/20144,263
Load More Insider Transactions
FUNDS WITH A POSITION IN THERAVANCE BIOPHARMA INC
Fund# Shares Owned% of Portfolio% ChangeInvesting Style
BAUPOST GROUP LLC/MA7,419,2261.82%No changeValue
BLACKROCK INC.4,587,8340.00131%0.46%Other
GEODE CAPITAL MANAGEMENT, LLC994,0000.00117%-6.33%Other
D. E. SHAW & CO., INC.851,2080.00836%23.44%Other
TUDOR INVESTMENT CORP ET AL10,0830.00091%-90.64%Event Driven, Other
ROYCE & ASSOCIATES LP59,0090.00613%No changeValue
BALYASNY ASSET MANAGEMENT L.P.13,6990.00024%ExitedEvent Driven
CHANGE IN SHARES OUTSTANDING FOR THERAVANCE BIOPHARMA INC
STOCK BUYBACKS FOR THERAVANCE BIOPHARMA INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
12/31/2023
09/30/2023
-5.75%
1Q
12/31/2023
06/30/2023
-12.93%
2Q
12/31/2023
03/31/2023
-21.58%
3Q
12/31/2023
12/31/2022
-26.70%
4Q
12/31/2023
09/30/2022
-34.65%
5Q
12/31/2023
06/30/2022
-35.29%
6Q
12/31/2023
03/31/2022
-34.41%
7Q
12/31/2023
12/31/2021
-33.32%
8Q
12/31/2023
09/30/2021
-32.92%
9Q
12/31/2023
06/30/2021
-24.85%
10Q
12/31/2023
03/31/2021
-23.48%
11Q
12/31/2023
12/31/2020
-22.57%
12Q
12/31/2023
09/30/2020
-22.04%
13Q
12/31/2023
06/30/2020
-21.49%
14Q
12/31/2023
03/31/2020
-17.01%
15Q
12/31/2023
12/31/2019
-12.04%
16Q
Load More

Period of Report: 12/31/2023

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
09/30/2023
-5.75%
1Q
06/30/2023
-12.93%
2Q
03/31/2023
-21.58%
3Q
12/31/2022
-26.70%
4Q
09/30/2022
-34.65%
5Q
06/30/2022
-35.29%
6Q
03/31/2022
-34.41%
7Q
12/31/2021
-33.32%
8Q
09/30/2021
-32.92%
9Q
06/30/2021
-24.85%
10Q
03/31/2021
-23.48%
11Q
12/31/2020
-22.57%
12Q
09/30/2020
-22.04%
13Q
06/30/2020
-21.49%
14Q
03/31/2020
-17.01%
15Q
12/31/2019
-12.04%
16Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR THERAVANCE BIOPHARMA INC
LOADING...